Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases
Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent’s novel radiopharmaceutical therapy to target peritoneal disease... Read more.
Hypermine closes seed funding round to maximise mineral recovery and minimise environmental impact
With demand for critical minerals like copper surging, Hypermine’s laser-based hyperspectral mineralogy sensor, developed at VTT, boosts decision accuracy... Read more.
Fujitsu awarded contract to design next-generation flagship supercomputer FugakuNEXT
Accelerating scientific and technological innovation with Made-in-Japan CPU technology KAWASAKI, Japan, June 18, 2025 /PRNewswire/ — Fujitsu Limited today... Read more.
Rockefeller Foundation Adds Govind Iyer to Board of Trustees
NEW YORK, June 18, 2025 /PRNewswire/ — The Rockefeller Foundation is pleased to announce that Mr. Govind Iyer, global business executive and philanthropic... Read more.
IEP – ‘The Great Fragmentation’ Driving Conflict: World Peace Plummets
LONDON, June 18, 2025 /PRNewswire/ — The 2025 Global Peace Index (GPI), released today by the Institute for Economics & Peace (IEP), reveals a continuing... Read more.
The Great Lighting Revolution: Americans Switch On to Mood-Boosting Home Lighting
Govee’s new “Life is Colorful” campaign aims to inspire people to bring more color to their homes as lighting takes center stage in the home experience ... Read more.
NETMARBLE OPENS GLOBAL PRE-REGISTRATION FOR NEW MASSIVE PET BRAWL RPG STONEAGE: PET WORLD
SEOUL, South Korea, June 17, 2025 /PRNewswire/ — Netmarble, a leading developer and publisher of high-quality games, has officially opened global pre-registrations... Read more.
Global Times: China, C.Asian countries jointly form China-Central Asia Spirit: Xi
BEIJING, June 17, 2025 /PRNewswire/ — Chinese President Xi Jinping said Tuesday that China and Central Asian countries have explored and formed the China-Central... Read more.
Caris Life Sciences Announces Pricing of Initial Public Offering
IRVING, Texas, June 17, 2025 /PRNewswire/ — Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine... Read more.
Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds
STATEN ISLAND, N.Y., June 17, 2025 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage... Read more.